Filter
287
Filtered Results: 287
Text search:
FDA
US
Food
&
Drug
Administration
Featured
Recommendations
27
New Publications
64
Language
Document type
No document type
159
Guidelines
56
Studies & Reports
43
Manuals
12
Fact sheets
8
Strategic & Response Plan
3
Training Material
2
Resource Platforms
2
Brochures
1
Situation Updates
1
Countries / Regions
India
13
Myanmar / Burma
8
Philippines
7
Russia
7
Ghana
6
USA
6
Western and Central Europe
5
Global
4
Latin America and the Carribbean
4
Uganda
4
South Sudan
4
Thailand
3
Syria
3
Nigeria
3
Germany
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
South Africa
3
Nepal
2
Rwanda
2
Africa
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Angola
2
Tajikistan
1
Sierra Leone
1
Singapore
1
Senegal
1
Peru
1
Mozambique
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Paraguay
1
Argentina
1
Brazil
1
Namibia
1
Sudan
1
Botswana
1
Indonesia
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
53
Pharmacy & Technologies
9
Public Health
8
Women & Child Health
6
Key Resources
5
Capacity Building
3
Toolboxes
COVID-19
37
Mental Health
32
TB
30
HIV
29
AMR
22
Pharmacy
15
Ebola & Marburg
13
Specific Hazards
9
NTDs
8
NCDs
7
Rapid Response
5
Planetary Health
5
Refugee
4
Cholera
2
Conflict
2
Zika
2
Natural Hazards
1
Disability
1
Caregiver
1
Health Financing Toolbox
1
Global Health Education
1
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
Troubles anxieux
Chapitre F.1
Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Mental Health Information
Accessed April 16, 2019
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de...
Временное руководство23 декабря 2020 г.
This Guide contains information, guidelines, diagrams and other materials addressed to medical practitioners who are engaged in the treatment of casualties of chemical weapons. It is made available to the public for information purposes, but is not intended to be used by the public. All decisions re...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Este documento apresenta uma orientação provisória sobre a gestão do fornecimento de sangue em resposta à pandemia da doença causada pelo novo coronavírus (COVID-19). É dirigido a serviços de hemoterapia, autoridades nacionais de saúde, e outros responsáveis pelo fornecimento de sangue e ...
Building laboratory testing capacity
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
30th World AIDS Day Report
STAR Initiative, Unitaid and World Health Organization December 2018
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
